Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on securities transactions by management and related persons for the period of December 1, 2024, to December 31, 2024. The report was signed on January 7, 2024, and complies with Article 11 of CVM Instruction #358/2002. The filing covers the Board of Directors, Management, and the Fiscal Council.
Key Financial Metrics and Transactions
The filing does not provide consolidated financial statements, revenue, profit, cash flow, or debt metrics. It exclusively details insider trading activity:
- Board of Directors: No net change in holdings. Two ownership transfers of 1,861,070 common shares each occurred on December 9 at a price of R$2.465577 per share. Final balance: 10,683,856 common shares and 776,180 ADRs.
- Management: Significant net increase in holdings.
- Sales: Multiple sales of common shares occurred on December 3, 5, 18, 26, and 27 via brokers (XP Corretora, Itaú Corretora, BTG Pactual, C6 Bank). Prices ranged from approximately R$12.02 to R$14.38.
- Acquisitions: Delivery of restricted shares occurred on December 1 and 9. This included 463,613 and 509,662 common shares, and 176,209 ADRs.
- Net Result: Common shares increased from 3,934,920 to 4,564,523. ADRs increased from 19,790 to 195,999.
- Fiscal Council: No transactions reported. Holdings remained at 0 common shares.
Material Changes
The filing does not provide comparative financial data against prior periods. The primary material change is the increase in Management's equity position due to the vesting/delivery of restricted shares, which outweighed the volume of shares sold during the month.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, risk factors, or contingencies. It is strictly a disclosure of insider trading activity.
Investor Verification Checklist
- Verify the total volume of restricted shares vested by Management in December 2024 versus the volume of shares sold.
- Confirm the specific identities of the Management members involved in the sales and acquisitions, as the filing provides consolidated data only.
- Review the price range of insider sales (R$12.02 - R$14.38) against the broader market performance for Ambev during December 2024.
- Note the discrepancy between the transaction period (December 2024) and the signature date (January 7, 2024) in the source text, which may indicate a data entry error in the filing or a specific reporting lag.